DNA stock forecast
Our latest prediction for Ginkgo Bioworks Holdings Inc's stock price was made on the Nov. 21, 2023 when the stock price was at 1.43$.
In the short term (2weeks), DNA's stock price should underperform the market by -0.34%. During that period the price should oscillate between -7.69% and +4.37%.
In the medium term (3months), DNA's stock price should outperform the market by 2.67%. During that period the price should oscillate between -27.16% and +10.33%.
Get email alertsCreate a solid portfolio with DNA
About Ginkgo Bioworks Holdings Inc
the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.
At the moment the company generates 1133M USD in revenues.
On its last earning announcement, the company reported a loss of -0.77$ per share.
The book value per share is 0.93$
Three months stock forecastNov. 21, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1133M | - | -920M | - | -857M | -0.77 | - | - | 1972M | 0.93 | - | - | - |